Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Advances in metallodrugs : preparation and applications in medicinal chemistry / / edited by Shahid-ul-Islam, Athar Adil Hashmi, Salman Ahmad Khan
| Advances in metallodrugs : preparation and applications in medicinal chemistry / / edited by Shahid-ul-Islam, Athar Adil Hashmi, Salman Ahmad Khan |
| Pubbl/distr/stampa | Hoboken, NJ : , : Wiley, , ℗2020 |
| Descrizione fisica | 1 online resource (427 pages) |
| Disciplina | 615.19 |
| Collana | Emerging trends in medicinal and pharmaceutical chemistry |
| Soggetto topico | Metals - Therapeutic use |
| ISBN |
1-119-64100-4
1-119-64101-2 1-119-64086-5 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910554822903321 |
| Hoboken, NJ : , : Wiley, , ℗2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Advances in metallodrugs : preparation and applications in medicinal chemistry / / edited by Shahid-ul-Islam, Athar Adil Hashmi, Salman Ahmad Khan
| Advances in metallodrugs : preparation and applications in medicinal chemistry / / edited by Shahid-ul-Islam, Athar Adil Hashmi, Salman Ahmad Khan |
| Pubbl/distr/stampa | Hoboken, NJ : , : Wiley, , ℗2020 |
| Descrizione fisica | 1 online resource (427 pages) |
| Disciplina | 615.19 |
| Collana | Emerging trends in medicinal and pharmaceutical chemistry |
| Soggetto topico | Metals - Therapeutic use |
| ISBN |
1-119-64100-4
1-119-64101-2 1-119-64086-5 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910819993503321 |
| Hoboken, NJ : , : Wiley, , ℗2020 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Handbook of metallonutraceuticals / / edited by Yashwant Vishnupant Pathak, Jayant Nemchand Lokhande
| Handbook of metallonutraceuticals / / edited by Yashwant Vishnupant Pathak, Jayant Nemchand Lokhande |
| Pubbl/distr/stampa | Boca Raton : , : Taylor & Francis, , [2014] |
| Descrizione fisica | 1 online resource (346 p.) |
| Disciplina | 613.2/8 |
| Collana | Nutraceuticals |
| Soggetto topico |
Metals - Physiological effect
Metals - Therapeutic use |
| ISBN |
0-429-15163-2
1-4398-3699-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Contents; Series Preface; Foreword; Preface; Editors; Contributors; Chapter 1: Concept, Definition, and Need for Metallonutraceuticals; Chapter 2: Roles of Metals in Metabolism; Chapter 3: Ethnopharmacology and Ethnomedicine of Metals; Chapter 4: Characterization of Metallonutraceuticals; Chapter 5: Characterization, Bioavailability, and Drug Interactions of Metallonutraceuticals; Chapter 6: Therapeutic Applications of Nanometals; Chapter 7: Metallonanotherapeutics for Neurodegenerative Diseases; Chapter 8: Nanometals and Complexes in Cancer Diagnosis and Therapy
Chapter 9: Application of Metals in Traditional Chinese MedicineChapter 10: Metalloenzymes : Relevance in Biological Systems and Potential Applications; Chapter 11: Application of Nanosilver in Nutraceuticals; Chapter 12: Regulatory Pathways and Intellectual Property Rights for Metallonutraceuticals; Chapter 13: Gold Nanoparticles : A Promising Nanometallic Drug Delivery System with Many Therapeutic Applications; Back Cover |
| Record Nr. | UNINA-9910786833703321 |
| Boca Raton : , : Taylor & Francis, , [2014] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Handbook of metallonutraceuticals / / edited by Yashwant Vishnupant Pathak, Jayant Nemchand Lokhande
| Handbook of metallonutraceuticals / / edited by Yashwant Vishnupant Pathak, Jayant Nemchand Lokhande |
| Pubbl/distr/stampa | Boca Raton : , : Taylor & Francis, , [2014] |
| Descrizione fisica | 1 online resource (346 p.) |
| Disciplina | 613.2/8 |
| Collana | Nutraceuticals |
| Soggetto topico |
Metals - Physiological effect
Metals - Therapeutic use |
| ISBN |
0-429-15163-2
1-4398-3699-X |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Front Cover; Contents; Series Preface; Foreword; Preface; Editors; Contributors; Chapter 1: Concept, Definition, and Need for Metallonutraceuticals; Chapter 2: Roles of Metals in Metabolism; Chapter 3: Ethnopharmacology and Ethnomedicine of Metals; Chapter 4: Characterization of Metallonutraceuticals; Chapter 5: Characterization, Bioavailability, and Drug Interactions of Metallonutraceuticals; Chapter 6: Therapeutic Applications of Nanometals; Chapter 7: Metallonanotherapeutics for Neurodegenerative Diseases; Chapter 8: Nanometals and Complexes in Cancer Diagnosis and Therapy
Chapter 9: Application of Metals in Traditional Chinese MedicineChapter 10: Metalloenzymes : Relevance in Biological Systems and Potential Applications; Chapter 11: Application of Nanosilver in Nutraceuticals; Chapter 12: Regulatory Pathways and Intellectual Property Rights for Metallonutraceuticals; Chapter 13: Gold Nanoparticles : A Promising Nanometallic Drug Delivery System with Many Therapeutic Applications; Back Cover |
| Record Nr. | UNINA-9910827405103321 |
| Boca Raton : , : Taylor & Francis, , [2014] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Metal-based drugs
| Metal-based drugs |
| Pubbl/distr/stampa | [London], : [Freund Pub. House], [1994]- |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Metals - Therapeutic use
Pharmaceutical chemistry Drugs Chemistry, Pharmaceutical Metals - therapeutic use Pharmaceutical Preparations |
| Soggetto genere / forma | Periodicals. |
| ISSN | 1687-5486 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910136268403321 |
| [London], : [Freund Pub. House], [1994]- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Metal-based drugs
| Metal-based drugs |
| Pubbl/distr/stampa | [London], : [Freund Pub. House], [1994]- |
| Descrizione fisica | 1 online resource |
| Soggetto topico |
Metals - Therapeutic use
Pharmaceutical chemistry Drugs Chemistry, Pharmaceutical Metals - therapeutic use Pharmaceutical Preparations |
| Soggetto genere / forma | Periodicals. |
| ISSN | 1687-5486 |
| Formato | Materiale a stampa |
| Livello bibliografico | Periodico |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996208979803316 |
| [London], : [Freund Pub. House], [1994]- | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Metallotherapeutic drugs and metal-based diagnostic agents [[electronic resource] ] : the use of metals in medicine / / [edited by] Marcel Gielen, Edward R.T. Tiekink
| Metallotherapeutic drugs and metal-based diagnostic agents [[electronic resource] ] : the use of metals in medicine / / [edited by] Marcel Gielen, Edward R.T. Tiekink |
| Pubbl/distr/stampa | Hoboken, N.J., : Wiley, c2005 |
| Descrizione fisica | 1 online resource (644 p.) |
| Disciplina |
615.23
615/.23 |
| Altri autori (Persone) |
GielenM <1938-> (Marcel)
TiekinkEdward R. T |
| Soggetto topico |
Metals - Therapeutic use
Metals - Diagnostic use |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-23877-1
9786610238774 0-470-29820-0 0-470-86404-4 0-470-86405-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
METALLOTHERAPEUTIC DRUGS AND METAL-BASED DIAGNOSTIC AGENTS; Contents; List of Contributors; Preface; 1 (3)Li Lithium Metallotherapeutics; 1.1 Introduction; 1.2 The Inorganic Chemistry of Lithium; 1.3 Biology of Lithium; 1.3.1 The history of lithium therapeutics; 1.3.2 Lithium and the body; 1.4 Targets of Lithium; 1.4.1 Glycogen synthase kinase-3; 1.4.2 Inositol phosphate signalling; 1.5 Lithium Therapeutics; 1.5.1 Bipolar disorder and schizophrenia; 1.5.2 Alzheimer's disease; 1.5.3 Ischemia (stroke); 1.5.4 Adverse effects; Acknowledgements; References
2 (5)B Boron Compounds as Therapeutic Drugs2.1 Boron Neutron Capture Therapy; 2.2 Classes of Boron Compounds for Potential Use in BNCT; 2.2.1 DNA binders; 2.2.2 Boron-containing amino acids and related peptides; 2.2.3 Boron-containing nucleic acid precursors; 2.3 Phosphates, Phosphonates and Phosphoramidates; 2.4 Amines; 2.5 Boron Analogues of Pyrophosphates; 2.6 Boronated Polyamines; 2.7 Carbohydrates; 2.8 Lipoproteins; 2.9 Lipids and Phospholipids; 2.10 Radiation Sensitizers; 2.11 Cyclic Thiourea Derivatives 2.12 Central Nervous System (CNS) Depressants: Promazines, Hydantoins and Barbiturates2.13 Hydantoins and Barbiturates; 2.14 Oligonucleotide Antisense Agents; 2.15 Hormones; 2.16 Liposomes; 2.17 Conclusions; Acknowledgements; References; 3 (12)Mg The Role of Magnesium as a Metallotherapeutic Drug; 3.1 Introduction; 3.2 Magnesium as a Drug; 3.2.1 Gestational hypertension, preeclampsia and eclampsia; 3.2.2 Asthma; 3.2.3 Stroke; 3.2.4 Acute myocardial infarction; 3.2.5 Arrhythmias; 3.2.6 Miscellaneous; References; 4 (13)Al Aluminum Metallotherapeutics; 4.1 Introduction; 4.2 Adjuvants; 4.2.1 Alum 4.2.2 Al(OH)(3)4.2.3 Aluminum phosphate; 4.3 Antacids; 4.3.1 Aluminum hydroxide; 4.3.2 Aluminum glycinate; 4.3.3 Peptic ulcer disease; 4.3.4 Bismuth aluminum carbonate; 4.3.5 Bismuth-magnesium-sodium alumino-silicate; 4.4 Phosphate Binders; 4.4.1 Basic aluminum carbonate; 4.4.2 Alumino-silicates; 4.5 Alginate Raft Formulations; 4.6 Blistering Diseases in the Elderly; 4.7 Metabolic Diseases and Aluminum; 4.8 Anti-malarial Substances; 4.9 Potential Aluminum Toxicity; 4.10 Conclusions; References; 5 (14)Si Biological Activity of Organosilicon Compounds; 5.1 Introduction 5.2 Organosilicon Modification5.2.1 O-, S- and N-Silylation; 5.2.2 C-Silylation; 5.3 Sila Analogues; 5.4 Specific Organosilicon Compounds; References; 6 (20)Ca The Role of Calcium as a Metallotherapeutic Drug; 6.1 Introduction; 6.2 Calcium Homeostasis; 6.3 Hormonal Regulation of Calcium Metabolism; 6.4 Optimal Amount of Dietary Calcium Intake and Benefits of Calcium Supplementation; 6.5 Osteoporosis; 6.6 Hypertension; 6.7 Hypertension in Pregnancy and Preeclampsia; 6.8 Colon Cancer; 6.9 Weight Control and Regulation of Body Fat; 6.10 Periodontal Disease; 6.11 Kidney Stones 6.12 Calcium Supplements: Side Effects |
| Record Nr. | UNINA-9910147221003321 |
| Hoboken, N.J., : Wiley, c2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Metallotherapeutic drugs and metal-based diagnostic agents [[electronic resource] ] : the use of metals in medicine / / [edited by] Marcel Gielen, Edward R.T. Tiekink
| Metallotherapeutic drugs and metal-based diagnostic agents [[electronic resource] ] : the use of metals in medicine / / [edited by] Marcel Gielen, Edward R.T. Tiekink |
| Pubbl/distr/stampa | Hoboken, N.J., : Wiley, c2005 |
| Descrizione fisica | 1 online resource (644 p.) |
| Disciplina |
615.23
615/.23 |
| Altri autori (Persone) |
GielenM <1938-> (Marcel)
TiekinkEdward R. T |
| Soggetto topico |
Metals - Therapeutic use
Metals - Diagnostic use |
| ISBN |
1-280-23877-1
9786610238774 0-470-29820-0 0-470-86404-4 0-470-86405-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
METALLOTHERAPEUTIC DRUGS AND METAL-BASED DIAGNOSTIC AGENTS; Contents; List of Contributors; Preface; 1 (3)Li Lithium Metallotherapeutics; 1.1 Introduction; 1.2 The Inorganic Chemistry of Lithium; 1.3 Biology of Lithium; 1.3.1 The history of lithium therapeutics; 1.3.2 Lithium and the body; 1.4 Targets of Lithium; 1.4.1 Glycogen synthase kinase-3; 1.4.2 Inositol phosphate signalling; 1.5 Lithium Therapeutics; 1.5.1 Bipolar disorder and schizophrenia; 1.5.2 Alzheimer's disease; 1.5.3 Ischemia (stroke); 1.5.4 Adverse effects; Acknowledgements; References
2 (5)B Boron Compounds as Therapeutic Drugs2.1 Boron Neutron Capture Therapy; 2.2 Classes of Boron Compounds for Potential Use in BNCT; 2.2.1 DNA binders; 2.2.2 Boron-containing amino acids and related peptides; 2.2.3 Boron-containing nucleic acid precursors; 2.3 Phosphates, Phosphonates and Phosphoramidates; 2.4 Amines; 2.5 Boron Analogues of Pyrophosphates; 2.6 Boronated Polyamines; 2.7 Carbohydrates; 2.8 Lipoproteins; 2.9 Lipids and Phospholipids; 2.10 Radiation Sensitizers; 2.11 Cyclic Thiourea Derivatives 2.12 Central Nervous System (CNS) Depressants: Promazines, Hydantoins and Barbiturates2.13 Hydantoins and Barbiturates; 2.14 Oligonucleotide Antisense Agents; 2.15 Hormones; 2.16 Liposomes; 2.17 Conclusions; Acknowledgements; References; 3 (12)Mg The Role of Magnesium as a Metallotherapeutic Drug; 3.1 Introduction; 3.2 Magnesium as a Drug; 3.2.1 Gestational hypertension, preeclampsia and eclampsia; 3.2.2 Asthma; 3.2.3 Stroke; 3.2.4 Acute myocardial infarction; 3.2.5 Arrhythmias; 3.2.6 Miscellaneous; References; 4 (13)Al Aluminum Metallotherapeutics; 4.1 Introduction; 4.2 Adjuvants; 4.2.1 Alum 4.2.2 Al(OH)(3)4.2.3 Aluminum phosphate; 4.3 Antacids; 4.3.1 Aluminum hydroxide; 4.3.2 Aluminum glycinate; 4.3.3 Peptic ulcer disease; 4.3.4 Bismuth aluminum carbonate; 4.3.5 Bismuth-magnesium-sodium alumino-silicate; 4.4 Phosphate Binders; 4.4.1 Basic aluminum carbonate; 4.4.2 Alumino-silicates; 4.5 Alginate Raft Formulations; 4.6 Blistering Diseases in the Elderly; 4.7 Metabolic Diseases and Aluminum; 4.8 Anti-malarial Substances; 4.9 Potential Aluminum Toxicity; 4.10 Conclusions; References; 5 (14)Si Biological Activity of Organosilicon Compounds; 5.1 Introduction 5.2 Organosilicon Modification5.2.1 O-, S- and N-Silylation; 5.2.2 C-Silylation; 5.3 Sila Analogues; 5.4 Specific Organosilicon Compounds; References; 6 (20)Ca The Role of Calcium as a Metallotherapeutic Drug; 6.1 Introduction; 6.2 Calcium Homeostasis; 6.3 Hormonal Regulation of Calcium Metabolism; 6.4 Optimal Amount of Dietary Calcium Intake and Benefits of Calcium Supplementation; 6.5 Osteoporosis; 6.6 Hypertension; 6.7 Hypertension in Pregnancy and Preeclampsia; 6.8 Colon Cancer; 6.9 Weight Control and Regulation of Body Fat; 6.10 Periodontal Disease; 6.11 Kidney Stones 6.12 Calcium Supplements: Side Effects |
| Record Nr. | UNINA-9910830892403321 |
| Hoboken, N.J., : Wiley, c2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Metallotherapeutic drugs and metal-based diagnostic agents : the use of metals in medicine / / [edited by] Marcel Gielen, Edward R.T. Tiekink
| Metallotherapeutic drugs and metal-based diagnostic agents : the use of metals in medicine / / [edited by] Marcel Gielen, Edward R.T. Tiekink |
| Pubbl/distr/stampa | Hoboken, N.J., : Wiley, c2005 |
| Descrizione fisica | 1 online resource (644 p.) |
| Disciplina | 615/.23 |
| Altri autori (Persone) |
GielenM <1938-> (Marcel)
TiekinkEdward R. T |
| Soggetto topico |
Metals - Therapeutic use
Metals - Diagnostic use |
| ISBN |
1-280-23877-1
9786610238774 0-470-29820-0 0-470-86404-4 0-470-86405-2 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
METALLOTHERAPEUTIC DRUGS AND METAL-BASED DIAGNOSTIC AGENTS; Contents; List of Contributors; Preface; 1 (3)Li Lithium Metallotherapeutics; 1.1 Introduction; 1.2 The Inorganic Chemistry of Lithium; 1.3 Biology of Lithium; 1.3.1 The history of lithium therapeutics; 1.3.2 Lithium and the body; 1.4 Targets of Lithium; 1.4.1 Glycogen synthase kinase-3; 1.4.2 Inositol phosphate signalling; 1.5 Lithium Therapeutics; 1.5.1 Bipolar disorder and schizophrenia; 1.5.2 Alzheimer's disease; 1.5.3 Ischemia (stroke); 1.5.4 Adverse effects; Acknowledgements; References
2 (5)B Boron Compounds as Therapeutic Drugs2.1 Boron Neutron Capture Therapy; 2.2 Classes of Boron Compounds for Potential Use in BNCT; 2.2.1 DNA binders; 2.2.2 Boron-containing amino acids and related peptides; 2.2.3 Boron-containing nucleic acid precursors; 2.3 Phosphates, Phosphonates and Phosphoramidates; 2.4 Amines; 2.5 Boron Analogues of Pyrophosphates; 2.6 Boronated Polyamines; 2.7 Carbohydrates; 2.8 Lipoproteins; 2.9 Lipids and Phospholipids; 2.10 Radiation Sensitizers; 2.11 Cyclic Thiourea Derivatives 2.12 Central Nervous System (CNS) Depressants: Promazines, Hydantoins and Barbiturates2.13 Hydantoins and Barbiturates; 2.14 Oligonucleotide Antisense Agents; 2.15 Hormones; 2.16 Liposomes; 2.17 Conclusions; Acknowledgements; References; 3 (12)Mg The Role of Magnesium as a Metallotherapeutic Drug; 3.1 Introduction; 3.2 Magnesium as a Drug; 3.2.1 Gestational hypertension, preeclampsia and eclampsia; 3.2.2 Asthma; 3.2.3 Stroke; 3.2.4 Acute myocardial infarction; 3.2.5 Arrhythmias; 3.2.6 Miscellaneous; References; 4 (13)Al Aluminum Metallotherapeutics; 4.1 Introduction; 4.2 Adjuvants; 4.2.1 Alum 4.2.2 Al(OH)(3)4.2.3 Aluminum phosphate; 4.3 Antacids; 4.3.1 Aluminum hydroxide; 4.3.2 Aluminum glycinate; 4.3.3 Peptic ulcer disease; 4.3.4 Bismuth aluminum carbonate; 4.3.5 Bismuth-magnesium-sodium alumino-silicate; 4.4 Phosphate Binders; 4.4.1 Basic aluminum carbonate; 4.4.2 Alumino-silicates; 4.5 Alginate Raft Formulations; 4.6 Blistering Diseases in the Elderly; 4.7 Metabolic Diseases and Aluminum; 4.8 Anti-malarial Substances; 4.9 Potential Aluminum Toxicity; 4.10 Conclusions; References; 5 (14)Si Biological Activity of Organosilicon Compounds; 5.1 Introduction 5.2 Organosilicon Modification5.2.1 O-, S- and N-Silylation; 5.2.2 C-Silylation; 5.3 Sila Analogues; 5.4 Specific Organosilicon Compounds; References; 6 (20)Ca The Role of Calcium as a Metallotherapeutic Drug; 6.1 Introduction; 6.2 Calcium Homeostasis; 6.3 Hormonal Regulation of Calcium Metabolism; 6.4 Optimal Amount of Dietary Calcium Intake and Benefits of Calcium Supplementation; 6.5 Osteoporosis; 6.6 Hypertension; 6.7 Hypertension in Pregnancy and Preeclampsia; 6.8 Colon Cancer; 6.9 Weight Control and Regulation of Body Fat; 6.10 Periodontal Disease; 6.11 Kidney Stones 6.12 Calcium Supplements: Side Effects |
| Record Nr. | UNINA-9910877338303321 |
| Hoboken, N.J., : Wiley, c2005 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Metals in medicine / / James C. Dabrowiak
| Metals in medicine / / James C. Dabrowiak |
| Autore | Dabrowiak James C. |
| Edizione | [Second edition.] |
| Pubbl/distr/stampa | Hoboken, New Jersey : , : John Wiley & Sons Inc., , 2017 |
| Descrizione fisica | 1 online resource (480 pages) |
| Disciplina | 615/.231 |
| Collana | Inorganic Chemistry: a Textbook Series |
| Soggetto topico | Metals - Therapeutic use |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-119-19134-3
1-119-19131-9 1-119-19137-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Inorganic chemistry basics -- Metallo-drugs and their action -- Platinum drugs for treating cancer -- Anticancer agents beyond cisplatin -- Responsive metal complexes -- Metal complexes for treating arthritis and diabetes -- Metal complexes for killing parasites, bacteria, and viruses -- Metal ion imbalance in the body -- Metal complexes for detecting disease -- Nanomedicine. |
| Record Nr. | UNINA-9910271058403321 |
Dabrowiak James C.
|
||
| Hoboken, New Jersey : , : John Wiley & Sons Inc., , 2017 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
